AbCellera Biologics Inc (ABCL)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |||||
| Total Revenue | 21.55M | 12.19M | 10.06M | 6.6M | 9.18M | 9.95M | 7.32M | 6.51M |
| Operating Income | -36.22M | -64.87M | -51.39M | -54.89M | -66.05M | -54.89M | -93.45M | -93.66M |
| Pre Tax Income | -31.41M | -48.15M | -38M | -39.28M | -48.6M | -42.75M | -48.19M | -62.63M |
| Net Income | -29.89M | -40.11M | -30.53M | -28.61M | -47.15M | -40.61M | -36.93M | -51.11M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -41.89M | -57.91M | -48.78M | -50.02M | -59.57M | -53.15M | -59.52M | -72.24M |
| EBITDA | -20.86M | -57.75M | -44.13M | -47.48M | -56.94M | -48.13M | -55.42M | -55.37M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 233.16M | 375.2M | 485.42M | 38.03M |
| Operating Income | 183.17M | 249.93M | 282.95M | -237.21M |
| Pre Tax Income | 157.83M | 219.15M | 239.1M | -174.03M |
| Net Income | 118.92M | 153.46M | 158.52M | -146.4M |
| Preferred Dividends | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0.441 | 0.54 | 0.545 | -0.496 |
| EBIT | 191.49M | 267.42M | 293.5M | -216.28M |
| EBITDA | 188.45M | 267.18M | 316.05M | -206.31M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
